Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial.

Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial.

Item
http://www.wikidata.org/entity/Q43684973
Endothelial perturbations and therapeutic strategies in normal tissue radiation damageCost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapyRadiation-Induced Oral MucositisVasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model.The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapyReview of the complications associated with treatment of oropharyngeal cancer: a guide for the dental practitioner.Efficacy of Traditional Chinese Medicine in Xerostomia and Quality of Life during Radiotherapy for Head and Neck Cancer: A Prospective Pilot Study.Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.Two-stage autotransplantation of human submandibular gland: a novel approach to treat postradiogenic xerostomia.Sustained-release microspheres of amifostine for improved radio-protection, patient compliance, and reduced side effects.Two-stage autotransplantation of the human submandibular gland: First long-term results.
P2860

Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial.

Item
http://www.wikidata.org/entity/Q43684973
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Subcutaneous compared with int ...... 02 phase III randomized trial.
@en
Subcutaneous compared with int ...... 02 phase III randomized trial.
@nl
type
label
Subcutaneous compared with int ...... 02 phase III randomized trial.
@en
Subcutaneous compared with int ...... 02 phase III randomized trial.
@nl
prefLabel
Subcutaneous compared with int ...... 02 phase III randomized trial.
@en
Subcutaneous compared with int ...... 02 phase III randomized trial.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Subcutaneous compared with int ...... 02 phase III randomized trial.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921